• A Critical Review of Chinese Pharmacoeconomics Studies in the Last Five Years

    Nov 1, 2014, 00:00
  • Incidence and Risk of Cardiotoxicity Induced by Sunitinib in Patients with Renal Cell Carcinoma- A Population-Based Case-Control Study in Chinese Population

    Nov 1, 2014, 00:00
  • Using the Analytic Hierarchy Process To Derive Health State Utilities From Ordinal Preference Data

    Nov 1, 2014, 00:00
  • Efficacy Of Novel Dmards In Early Active Rheumatoid Arthritis- An Indirect Comparison

    Nov 1, 2014, 00:00
  • The Importance and Use of Drug Utilization Review and Pharmacoeconomics

    Nov 1, 2014, 00:00
  • The Differences Between Cancer Drug Approvals in Japan and the USA

    Nov 1, 2014, 00:00
  • Market Access and Reimbursement- The Increasing Role of Real-World Evidence

    Nov 1, 2014, 00:00
  • Health Care Stakeholders' Evaluation of A User-Friendly Tool Which Estimates Long-Term Health Gains Following the Reduction of Ldl Levels

    Nov 1, 2014, 00:00
  • Assessing Assessment- Does Health Technology Assessment Do Its Job of Controlling Costs Without Compromising Quality?

    Nov 1, 2014, 00:00
  • Management of Crises and Risks in German Hospitals - Factors Influencing Medication Errors

    Nov 1, 2014, 00:00
  • Economic Burden of Major Depressive Disorder (Mdd) in Five European Countries- Description of Resource use by Health State

    Nov 1, 2014, 00:00
  • Cost Comparison Among First Line Monoclonal Antibodies-Based Oncology Treatment Protocols

    Nov 1, 2014, 00:00
  • Valuing EQ-5D-5L- Does the Ordering of the Health Dimensions Impact on Health State Valuations?

    Nov 1, 2014, 00:00
  • Current Management and Barriers to Treatment for Wet Age-Related Macular Degeneration (Wamd)- Perspectives From Patients and Caregivers

    Nov 1, 2014, 00:00
  • What are the Key Driving Factors Behind RSA Decisions In Australia?

    Nov 1, 2014, 00:00
  • From Regulatory Approval to Subsidised Patient Access in the Asia-Pacific Region- A Comparison of Systems Across Australia, China, Japan, Korea, New Zealand, Taiwan And Thailand

    Nov 1, 2014, 00:00
  • A Comparison of Patient-Reported and Laboratory Outcomes Between Hemodialysis and Peritoneal Dialysis Patients in a Multi-Ethnic Asian Population

    Nov 1, 2014, 00:00
  • Cost-Benefit-Analysis of a Targeted Hospital Wide Pcr-Based Admission Screening for Mrsa in a German University Hospital – Consideration of a Six-Year Time Period

    Nov 1, 2014, 00:00
  • Impacts of Epro Data Collection Mode Selection on Patient Inclusion

    Nov 1, 2014, 00:00
  • Hta Studies On Orphan Drugs By Rebratsxmembers

    Nov 1, 2014, 00:00
  • A Comaprative Cross-Sectional Study On Health-Related Quality Of Life In Psoriasis From Hungary And Iran

    Nov 1, 2014, 00:00
  • The Incidence, Prevalence, and Survival of Malignant Melanoma in Taiwan

    Nov 1, 2014, 00:00
  • The Importance of Long-Term Surveillance of Stage IB Melanomas- Unexpectedly Low Survival Subsequent to Recurrence

    Nov 1, 2014, 00:00
  • Clinical Pathway And Health Care Resources Utilization Of A Patients Cohort At High Risk Of Cardiovascular Disease Of Local Health Care Unit (Asln°1) Of Milan- A Results Of Intervention On Secondary Prevention

    Nov 1, 2014, 00:00
  • Application of Threshold Value for Cost-Effectiveness in Recommendations Issued by Agency for Health Technology Assessment in Poland for Cancer Drug Technologies

    Nov 1, 2014, 00:00
  • Inadequate Pain Relief Among Patients With Primary Knee Osteoarthritis - Analysis From The Portuguese Sample Of The Survey Of Osteoarthritis Real World Therapies (Sort)

    Nov 1, 2014, 00:00
  • Costs Of Treating Cardiovascular Events In Germany- A Systematic Literature Review

    Nov 1, 2014, 00:00
  • HTA Approach in Italy. Structure, Methods, And Process Of Veneto Region's Evaluation Of Pharmaceutical Effectiveness Unit (Unità Di Valutazione Dell'efficacia Del Farmaco, Uvef)

    Nov 1, 2014, 00:00
  • A Comparison of the Impact of Rheumatic Diseases and Other Chronic Diseases on Early Retirement in Portugal

    Nov 1, 2014, 00:00
  • Assessment of Rural Health Purchasing Arrangements In China

    Nov 1, 2014, 00:00
  • Effective Prioritisation of National Health Technology Assessments

    Nov 1, 2014, 00:00
  • How Likely Warfarin Pharmacogenetic Test to be Cost-Effective in Thailand- A Threshold Analysis

    Nov 1, 2014, 00:00
  • Pharmacoeconomics and its Applications – Emerging Role in India

    Nov 1, 2014, 00:00
  • Costed Treatment Pathways of Diffuse Large B Cell Lymphoma in a UK Population-Based Cohort- A Patient Level Simulation Model

    Nov 1, 2014, 00:00
  • The Effects of Reforms, Price Cuts And Global Budget Implementation on Original/Generic Medicine Sales Which Have Annual Average Highest Amount Of Sales Between 2008-2013 In Turkey

    Nov 1, 2014, 00:00
  • Effects and Safety of Ceftriaxone Versus Levofloxacin in Treating Community-Acquired Pneumonia- A Sysytematic Review

    Nov 1, 2014, 00:00
  • Lubiprostone In Chronic Idiopathic Constipation- A Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00
  • Prospective Study on Cost-Effectiveness of Nurse Interviw Introducing Retesting With in Vitro Diagnostics (IVD) To Parents of Children With Suspected Food Allergy in Finland

    Nov 1, 2014, 00:00
  • Spontaneous Reporting of Adverse Drug Reactions in Geriatric Patients in India

    Nov 1, 2014, 00:00
  • Budget Impact Analysis of a Return-To-Work Intervention for Cancer Patients Shows Hospitals Bear the Costs, for Society to Enjoy the Benefits

    Nov 1, 2014, 00:00
  • Inclusion and Consideration of Patient Preferences in Amnog Early Benefit Assessments

    Nov 1, 2014, 00:00
  • Costs Per Successfully Treated Patient with Sofosbuvir in GT1 HCV

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Screening Syphilis Among Pregnant Women

    Nov 1, 2014, 00:00
  • Drug Utilization Review of Acid Suppressants (Durable) – an Audit to Assess the Utilization of Proton Pump Inhibitors and Histamine H2-Receptor Antagonists in Canadian Hospitals

    Nov 1, 2014, 00:00
  • Cost-Utility Analysis of Recommended Ranibizumab Regimen for Age-Related Macular Degeneration in China

    Nov 1, 2014, 00:00
  • Patient-Reported Fall Related Health Care Services in Elderly Women

    Nov 1, 2014, 00:00
  • Modelling Evolving Cancer Risk During Epidemiological Transition Using Economic Data

    Nov 1, 2014, 00:00
  • Examining the Economic Benefits of Lifestyle Intervention in Segments of A Prediabetic Population

    Nov 1, 2014, 00:00
  • Sensitivity Of The Safuca Questionnaire To Detect Differences Between Atrial Fibrillation Patients Treated With Vitamin-K Antagonist Against Those Treated With New Oral Anticoagulants

    Nov 1, 2014, 00:00
  • Simvastatin Plus Fenofibrate As A Fixed Dose Combination In The Treatment Of Mixed Dyslipidemia In Gree Budget Impact Analysis

    Nov 1, 2014, 00:00
  • Comparison in Methods Between National Institute for Health And Care Excellence (Nice) Submissions For Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt-2i)

    Nov 1, 2014, 00:00
  • Economic Evaluation Of Percent Free Psa For Prostate Cancer Detection In Taiwanese Men

    Nov 1, 2014, 00:00
  • Measuring Extent of Access For Nice Health Technology Assessment Decisions- Trends From 2008 to 2013

    Nov 1, 2014, 00:00
  • Preferences of Spanish Patients Over the Attributes of Biological Agents for the Treatment of Rheumatic Diseases Depending On the Administration Route

    Nov 1, 2014, 00:00
  • Mapping the Functional Assessment of Cancer Therapy – Breast (Fact-B) to the 5-Level Euroqol Group's 5-Dimention Questionnnaire (Eq-5d) Index in a Multi-Ethnic Asian Breast Cancer Patients

    Nov 1, 2014, 00:00
  • A Cost-Effectiveness Analysis Of Onabotulinumtoxina Verse. Best Supportive Care (bsc) For The Treatment Of Anticholinergic Treatment-Refractory Neurogenic Detrusor Overactivity (ndo)

    Nov 1, 2014, 00:00
  • The Impact of Discrimination, Victimization and Social Standing on Health-Related Quality of Life

    Nov 1, 2014, 00:00
  • Hierarchical Network Meta-Analysis Incorporating Ordering Constraints on Increasing Doses of Interventions - Application to Overactive Bladder Syndrome

    Nov 1, 2014, 00:00
  • French Utility Elicitation in Previously Treated European Patients with Indolent Non-Hodgkin Lymphoma (INHL)

    Nov 1, 2014, 00:00
  • Comparison of Health Care Resource use and Costs in Patients with Opioid Prescription Drug Dependence (Opd) Treated with Buprenorphine/Naloxone and Patients without Pharmacological Treatment- Retrospective Analysis of us Public Insurance Cl ...

    Nov 1, 2014, 00:00
  • Rates of Diagnosed Opioid Abuse Or Dependence and Incremental Direct Health Care Costs Among Patients With Long-Term Use of Immediate Release Hydrocodone

    Nov 1, 2014, 00:00
  • ARE TOTAL HEALTH CARE EXPENDITURES IMPACTED BY A NEW DIABETES DIAGNOSTIC FACTOR- HBA1C?

    Nov 1, 2014, 00:00
  • Study Of Costs Of The Cardiac And Diabetes Mellitus Patient In A Cardiology Hospital Of High Complexity

    Nov 1, 2014, 00:00
  • Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil

    Nov 1, 2014, 00:00
  • A Pilot Study of the Effectiveness of Treatment Patients With Hemophilia In Ukraine

    Nov 1, 2014, 00:00
  • Survey of Treatment Costs to Hepatitis C in China

    Nov 1, 2014, 00:00
  • Cost and Duration Of Regulatory Process in an Observational Study in Europe and USA

    Nov 1, 2014, 00:00
  • Impact of Generic Substitution On the Prescribing of Meprobamate-Containing Combination Analgesics In South Africa

    Nov 1, 2014, 00:00
  • Do new cancer drugs offer good value for money? the perspective of oncologists, payers, patients, and general population

    Nov 1, 2014, 00:00
  • The Efficacy of Oximes in Acute Human Organophosphorus Poisoning; An Updated Meta-Analysis

    Nov 1, 2014, 00:00
  • Persistence to Treatment of Chronic Hepatitis B Virus (Hbv) Infection- A Study Based on the French Ims Lifelink Treatment Dynamics (LTD) Database

    Nov 1, 2014, 00:00
  • Assessing Balance in Baseline Characteristics Using Different Propensity Adjusted Methods for Bipolar I Mixed Disorder Patients Initiating Asenapine Versus Other Oral Atypical Antipsychotics

    Nov 1, 2014, 00:00
  • Hipos-ER (Hypoglycemia in Portugal Observational Study – Emergency Room)- Clinical Outcomes in the Emergency Room

    Nov 1, 2014, 00:00
  • Are Cycles Needed in Markov Models? – The Continuous Model as a Simpler Approach

    Nov 1, 2014, 00:00
  • Cost-Utility Analysis (Cua) of First-Line Actinic Keratosis (Ak) Treatments in Finland

    Nov 1, 2014, 00:00
  • A Retrospective Cohort Study of Risk Factors for Death Among Humman Immunodeficiency Virus Infected Adult Patients

    Nov 1, 2014, 00:00
  • Modeling the Effect of Combining Alogliptin With Dual therapy in Type 2 Diabetes

    Nov 1, 2014, 00:00
  • Price Comparison in the European Pharmaceutical Market

    Nov 1, 2014, 00:00
  • Impacts of Lower Back Pain- Refinement of the Pain Assessment for Lower Back-Impacts Questionnaire (Pal-I) Using a Mixed Methods Approach

    Nov 1, 2014, 00:00
  • Cost Effectiveness Of Renal Denervation Therapy For The Treatment Of Resistant Hypertension In The Netherlands

    Nov 1, 2014, 00:00
  • Attitude Assessment of the Human Papilloma Virus (Hpv) in Hungary

    Nov 1, 2014, 00:00
  • Acute And Chronic Impact Of Cardiovascular Events On Health State Utilities

    Nov 1, 2014, 00:00
  • PROF DR Hasbullah Thabrany

    Nov 1, 2014, 00:00
  • The Grass is Always Greener on the Other Side or Why There Is Little Meaning in International Pharmaceutical Price Comparison

    Nov 1, 2014, 00:00
  • Cost and Resource Use of Managing Major Depressive Disorder (MDD) in China

    Nov 1, 2014, 00:00
  • Predictive Modeling to Assess Predictors of Treatment Success and Failure Among Combination Statin Therapy Patients

    Nov 1, 2014, 00:00
  • Comparative Effectiveness of Biological Agents With Diseases Modifying Anti-Rheumatic Drugs For Methotrexate Failure Rheumatoid Arthritis Patients- A Baysian Mixed Treatment Comparison

    Nov 1, 2014, 00:00
  • Comparison of Epidemiology and Drug Treatment in HER2 Negative Metastatic Breast Cancer (MBC) in EU5

    Nov 1, 2014, 00:00
  • Cost Per Response Analysis for Thrombopoietin Receptor Agonists (Tpo-Ras), In the Treatment of Adult Chronic Immune Thrombocytopenia (Itp) In Mexico

    Nov 1, 2014, 00:00
  • Direct Non-Medical Costs Of Rheumatoid Arthritis By Disease Level In Portugal

    Nov 1, 2014, 00:00
  • Economic Burden of Febrile Neutropenia in Solid Tumor and Lymphoma Patients- An Observational Study in Singapore

    Nov 1, 2014, 00:00
  • Validation of the Adherence Barriers Questionnaire (Abq) – An Instrument for Identifying Potential Risk Factors Associated With Medication-Related Non-Adherence

    Nov 1, 2014, 00:00
  • The Cost-Effectiveness of Biologic Dmards in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional Dmards

    Nov 1, 2014, 00:00
  • Prevalence of Metabolic Syndrome in Patients with Schizophrenia According to the Presence or Absence of Negative Symptoms

    Nov 1, 2014, 00:00
  • Association of Changes In Body Weight With Health Care Costs Among Patients With Newly-Diagnosed Type-2 Diabetes In Sweden

    Nov 1, 2014, 00:00
  • Prescription of Rosiglitazone and Pioglitazone Folowing Safety Warnings- A Comparative Analysis of Trends in Dispensing Patterns in Denmark and Germany From 2007 To 2013

    Nov 1, 2014, 00:00
  • Evaluation of Medicine Prescription Pattern Using World Health Organization Prescribing Indicators in Iran- A Cross-Sectional Study

    Nov 1, 2014, 00:00
  • Letting The Data Speak- A Shift of the Pharmaceutical Spending to Households in Greece

    Nov 1, 2014, 00:00
  • Productivity Loss and Resource Utilization in Individuals Providing Care for Adults with Schizophrenia in the 5eu

    Nov 1, 2014, 00:00
  • Provincial Entry of New Drugs In China

    Nov 1, 2014, 00:00
  • Adherence Rates For Peginterferon + Ribavirin Compared With Telaprevir + Peginterferon + Ribavirin In Medicaid And Commercial Patients Treated For Chronic Hepatitis C

    Nov 1, 2014, 00:00
  • Economic Impact of Combining Metformin with Dipeptidyl Peptidase Inhibitors In Diabetic Patients With Renal Failure

    Nov 1, 2014, 00:00
  • Experiences With Price Competition of Biosimilar Drugs in Hungary

    Nov 1, 2014, 00:00
  • What Really Matters? A Multi-View Perspective of One Patient's Hospital Experience

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Model of Dual-Mobility Cups for Total Hip Replacement in France

    Nov 1, 2014, 00:00
  • An Evaluation of Medical Resource Utilisation In Patients With Autosomal Dominant Polycystic Kidney Disease In Europe

    Nov 1, 2014, 00:00
  • Impact Of Pharmacoeconomic Guidelines on the Reimbursement Process of Medicines In Serbia In 2014

    Nov 1, 2014, 00:00
  • Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regionally Metastatic Melanoma- A Retrospective Database Analysis

    Nov 1, 2014, 00:00
  • Is the rule of halves applicable in Diabetes Type 2? Evidence from Greece

    Nov 1, 2014, 00:00
  • Optimizing Process Efficiency Through Implanting Reveal Linq Verse Reveal Xt/Dx From Three Spanish Hospital Perspective

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Aprepitant in Egyptian Patients Receiving Highly Emetogenic Therapy from the Third Party Payer Perspective

    Nov 1, 2014, 00:00
  • Cost-Minimization Analysis of Methadona Opioid Analgesic for Mexican Patients With Acute and Chronic Secondary Cancer As Rotation Option In Severe Pain

    Nov 1, 2014, 00:00
  • Recent Regulatory Reforms to Ensure Patient Safety in Clinical Research In India

    Nov 1, 2014, 00:00
  • A Prospective Pharmacoeconomic Study of Bilateral Prostaglandin/ Prostamide Therapy for Lowering Intraocular Pressure (Iop) in the Patients in South India

    Nov 1, 2014, 00:00
  • Budget Impect Analysis

    Nov 1, 2014, 00:00
  • A Cost-Effectiveness Evaluation for a New Therapy in HIV Treatment

    Nov 1, 2014, 00:00
  • Treatment Strategies For Stage Ib Cervical Cancer- A Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00
  • Variations In Treatment Patterns and Disease Severity Among Patients With Psoriasis Receiving Their First Biologic Therapy In Europe (Eu)

    Nov 1, 2014, 00:00
  • Shared Decision-Making in Women with Early Stage Breast Cancer and Implications for Long-Term Health-Related Quality of Life

    Nov 1, 2014, 00:00
  • Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of the New Biomarkers for Diagnosis of Acute Kidney Injury in Children After Cardiac Surgery

    Nov 1, 2014, 00:00
  • A Qualitative Assessment of Doctors Perception Towards the Quality of Pharmaceutical Care Services in Khyber Pakhtunkhwa, Pakistan

    Nov 1, 2014, 00:00
  • Markov Model-Based Economic Evaluation of Combination Therapy with Ezetimibe and Statin Monotherapy

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Amfepramone (Diethylpropion) for the Obesity Treatment In Mexico

    Nov 1, 2014, 00:00
  • Heal Rate In 4,190 Fresh Fractures Treated With Low-Intensity Pulsed Ultrasound (Lipus)

    Nov 1, 2014, 00:00
  • Application Of A Model Of Decision Based On Fuzzy Logic To Pharmacoeconomics- Ranibizumab Verse Aflibercert In AMD

    Nov 1, 2014, 00:00
  • Patterns and Predictors of Hospital Readmission in Taiwan

    Nov 1, 2014, 00:00
  • Misuse, Abuse, and Diversion of instanyl® (Fentanyl Nasal Spray) in France

    Nov 1, 2014, 00:00
  • The Impact of Economic Crisis on Suicide Rates in Greece

    Nov 1, 2014, 00:00
  • Modeling The Impact Of A Digital Health Feedback System In Uncontrolled Hypertensive Patients

    Nov 1, 2014, 00:00
  • Differential Item Functioning and the Eq-5d- Evidence From the Uk Hospital Episode Statistics

    Nov 1, 2014, 00:00
  • Economic Burden of Hospitalized Pneumonia from a Private Health Care System Perspective in Brazil

    Nov 1, 2014, 00:00
  • Hospital Cost of Thromboembolic Events in Breast or Prostate Cancer Patients

    Nov 1, 2014, 00:00
  • MODELLING HEALTH-RELATED QUALITY OF LIFE (HRQOL) LONGITUDINALLY. A BAYESIAN MIXED BETA REGRESSION APPROACH

    Nov 1, 2014, 00:00
  • Development of a Survey to Quantify Parents' Priorities for Vaccinating Children Against Rotavirus

    Nov 1, 2014, 00:00
  • What Is Working Well In Louisiana For Us Employers- A Descriptive Analysis of Employers Actively Engaged In Promoting Employee Health

    Nov 1, 2014, 00:00
  • Health Related Quality of Life (Hrqol) in Multiple Myeloma Patients Treated in a Tertiary Referral Hospital

    Nov 1, 2014, 00:00
  • Burden of Disease in Stage IV Non-Small Cell Lung Cancer- Comparing ALK Positive and ALK Negative Mutation Status in Egypt, Russia and the United Arab Emirates

    Nov 1, 2014, 00:00
  • The Impact of Long-Term Clinical Evidence on Cost-Effectiveness of Exenatide Once Weekly (Bydureon®) Versus Insulin Glargine for Patients With Type 2 Diabetes Mellitus (T2dm) From A Uk Nhs Perspective

    Nov 1, 2014, 00:00
  • Cost Effectiveness Analysis Of Mitraclip In Mitral Regurgitation For High Risk Patients

    Nov 1, 2014, 00:00
  • Cost Effective Analysis of Dry Powdered Inhalers Versus Metered Dose Inhalers of Salbutamol for Asthma in Rural Secondary Care Hospital of South India

    Nov 1, 2014, 00:00
  • Costs of Absenteeism In Psoriatic and Enteropathic Arthropathies Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012

    Nov 1, 2014, 00:00
  • An Economic Model to Compare the Different Empiric and First/Second Line Treatment Regimens for Suspected Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia

    Nov 1, 2014, 00:00
  • Sustainable Measurement of Response Shift in Prostate Cancer Patients- Adjusting Health Related Quality of Life with the Then-Test

    Nov 1, 2014, 00:00
  • Health Care Utilizations And Costs Of Insulin Patient-Driven Titration Versus Physician-Driven Titration- Evidence Based On A Clinical Trial Of Biphasic Insulin Aspart 30 Twice Daily In People With Type 2 Diabetes In China

    Nov 1, 2014, 00:00
  • Diagnosis And Management Of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Spain- The Ibis-C Study

    Nov 1, 2014, 00:00
  • Breast Cancer Awareness Survey

    Nov 1, 2014, 00:00
  • Health-Related Quality of Life In Patients With Cervical Cancer in Indonesia

    Nov 1, 2014, 00:00
  • The Prevalence and Disease Burden of Treatment-Resistant Depression - a Systematic Review of the Literature

    Nov 1, 2014, 00:00
  • Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia- Value of Information Analysis

    Nov 1, 2014, 00:00
  • Impact of Health Care Reform on Drug Reimbursement Decision-Making In Taiwan

    Nov 1, 2014, 00:00
  • Factors Influencing Job Satisfaction Among Nurses of Pafos General Hospital in Cyprus

    Nov 1, 2014, 00:00
  • Retrospective Public Health Impact of a Quadrivalent Influenza Vaccine in the United States Over the Period 2000-2014

    Nov 1, 2014, 00:00
  • Prevalence and Treatment of Chronic Lymphocytic Leukaemia (Cll) In Germany- An Analysis of Sickness Funds

    Nov 1, 2014, 00:00
  • Confirmation of the Factor Structure of the Proqol-HIV Questionnaire to Assess Health-Related Quality of Life in PLWHA

    Nov 1, 2014, 00:00
  • Impact of Apremilast on Physical Function over 52 weeks in Patients with Active Psoriatic Arthritis

    Nov 1, 2014, 00:00
  • An Overview of the Biosimilar Market in the Us

    Nov 1, 2014, 00:00
  • Economic Burden of Asthma in Vietnam- An Analysis from Patients' Perspective

    Nov 1, 2014, 00:00
  • Pediatrician's Perspective On Pneumococcal Conjugate Vaccines In India- An Exploratory Study

    Nov 1, 2014, 00:00
  • Analysis of ‘Revolving Door' Patients in Opioid Dependent Patients- the Impact of Treatment Discontinuation on Relapse Rates and Health Care Costs in us Public Health Insurance Claims

    Nov 1, 2014, 00:00
  • Pharmacoeconomic Research and Application In 10 Asian Countries Between 2003 and 2013- A Systematic Review

    Nov 1, 2014, 00:00
  • A Web Based Optimisation Model For A Portfolio Of Preventative Interventions Utilizing Multi Criteria Decision Analyses (Mcda) Framework

    Nov 1, 2014, 00:00
  • Cost-Effectiveness and Value of Information Analyses of Nutritional Support in Preventing Pressure Ulcers in High Risk Hospitalised Patients

    Nov 1, 2014, 00:00
  • Mcda Approach To Ranking Rare Diseases In Russia- Preliminary Results

    Nov 1, 2014, 00:00
  • Proposal for a Comprehensive Definition of Budget Impact Analysis

    Nov 1, 2014, 00:00
  • How Much the Appropriate Tobacco Price Would Be?- A Discrete Choice Experiment of General Public in Japan

    Nov 1, 2014, 00:00
  • Is G-Ba Strategically Discounting The Benefit Assessment of Relatively High Cost Drugs?

    Nov 1, 2014, 00:00
  • Risk Sharing Agreement Considerations for Pharmaceuticals in China Makret

    Nov 1, 2014, 00:00
  • Setting up the Right Scenarios for Cost-Effectiveness Analysis- An Example with Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients in China

    Nov 1, 2014, 00:00
  • Evaluation of Potential Waste Of Growth Hormone Across Available Growth Hormone Pen Devices And An Electronic Growth Hormone Delivery Device

    Nov 1, 2014, 00:00
  • Comparative Pharmacoeconomics Studies of Treatment for Major Depressive Disorder in China

    Nov 1, 2014, 00:00
  • Indirect Costs Among Patients with Hepatitis C Virus

    Nov 1, 2014, 00:00
  • Modelling Dependence Between Disability Status and Health Service Costs of People With Rheumatoid Arthritis in Hungary

    Nov 1, 2014, 00:00
  • Analysis of Cardiac Implants Recalls in the Last Decade- An International Comparison

    Nov 1, 2014, 00:00
  • Patient Access To Life-Saving Medication; Preventing Stock-Outs Due To Parallel Trade

    Nov 1, 2014, 00:00
  • Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Code Is Not Available- A Validation Study Comparing Medication/Prescriber Visit Based Algorithms To Diagnosis Codes

    Nov 1, 2014, 00:00
  • Impact on Hospitalization Derived from the Use of Denosumab for the Prevention of Skeletal-Related Events in Patients with Bone Metastases Secondary to Breast Cancer in Germany

    Nov 1, 2014, 00:00
  • Getting To Reimbursement Faster- Combining Randomised, Pragmatic, and Observational Clinical Trial Data

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Comparison Of Botulinum Toxin Type A Plus Best Supportive Care Versus Best Supportive Care Alone In The Treatment Of Idiopathic Overactive Bladder With Urinary Incontinence Among Patients Not Adequately Managed By Anticho ...

    Nov 1, 2014, 00:00
  • Budgetary Impact Analysis Of Reimbursement Varenicline In The Smoking Cessation Treatment Of Patients With Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease Or Type-2 Diabetes Mellitus- A National Health System Perspective In S ...

    Nov 1, 2014, 00:00
  • Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe

    Nov 1, 2014, 00:00
  • Usage of Self-Monitoring of Blood Glucose (Smbg) By Diabetes Therapy Type in India

    Nov 1, 2014, 00:00
  • Price Comparison Between the Essential and Non-Essential Anti-Infective Medicines Among National Reimbursement Drug List in China

    Nov 1, 2014, 00:00
  • The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2014, 00:00
  • Sofosbuvir For The Treatment Of Chronic Hepatitis C- A Comprehensive Cost-Effectiveness Analysis Across Hcv Genotypes, Pretreatment Conditions And Hiv Co-Infection

    Nov 1, 2014, 00:00
  • Examination of the Burden of Illness of U. S. Medicare Patients Diagnosed with Chronic Obstructive Pulmonary Disease

    Nov 1, 2014, 00:00
  • A Comparison of International Health Technology Assessment Systems – Does The Perfect System Exist?

    Nov 1, 2014, 00:00
  • Hipos-ER (Hypoglycemia in Portugal Observational Study – Emergency Room)- Clinical Outcomes in Admitted Patients

    Nov 1, 2014, 00:00
  • What are the Lifelong costs of Vaccinating one Individual? The French Case

    Nov 1, 2014, 00:00
  • Drug Therapy Problems in Patients on Antihypertensives with Antidiabetic Drugs in Two Tertiary Health Institutions in Niger Delta Region, Nigeria

    Nov 1, 2014, 00:00
  • Treatment and Monitoring of Venous Thromboembolism (VTE) Among Hospitalized Patients in China

    Nov 1, 2014, 00:00
  • The Effect of Insomnia and Insomnia Treatment Side Effects on Health Status, Work Productivity, and Health Care Resource Use

    Nov 1, 2014, 00:00
  • Evaluating Working Ability and Quality of Life of Patients with Multiple Sclerosis

    Nov 1, 2014, 00:00
  • Burden of Disease Caused by Influenza in Germany - A Retrospective Claims Database Analysis

    Nov 1, 2014, 00:00
  • Re-Validation of the Self-Injection Assessment Questionnaire© (Siaqv2.0©) in Rheumatoid Arthritis Patients on Certolizumab Pegol Treatment

    Nov 1, 2014, 00:00
  • Impact of Health Policy Changes on Trends of Pharmaceutical Market in Turkey

    Nov 1, 2014, 00:00
  • Real World Data in Oncology- Third- and Fourth-Line Treatments Administered in Metastatic Colon-Rectal Cancer (MCRC)

    Nov 1, 2014, 00:00
  • Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families- Observations from the Dosing Observational Study in Hemophilia (DOSE)

    Sep 1, 2014, 00:00
  • A Patient-Level Calibration Framework for Evaluating Surveillance Strategies- A Case Study of Mammographic Follow-Up After Early Breast Cancer

    Sep 1, 2014, 00:00
  • Table of Contents

    Sep 1, 2014, 00:00
  • Copyright/Subscription

    Sep 1, 2014, 00:00
  • Transitions between Care Settings in Dementia- Are They Relevant in Economic Terms?

    Sep 1, 2014, 00:00
  • Impact of Mental Health Comorbidities on Health Care Utilization and Expenditure in a Large US Managed Care Adult Population with ADHD

    Sep 1, 2014, 00:00
  • Instructions for Authors

    Sep 1, 2014, 00:00
  • The Nocturia Impact Diary- A Self-Reported Impact Measure to Complement the Voiding Diary

    Sep 1, 2014, 00:00
  • Mapping between the Roland Morris Questionnaire and Generic Preference-Based Measures

    Sep 1, 2014, 00:00
  • It’s Good to Have a Choice; Now Let’s Get More Data- Response to Armstrong et al.’s “Response to Lai et al., Development of a Symptom Index for Patients with Primary Brain Tumors”

    Sep 1, 2014, 00:00
  • Analyzing Overall Survival in Randomized Controlled Trials with Crossover and Implications for Economic Evaluation

    Sep 1, 2014, 00:00
  • Can Value-Based Insurance Impose Societal Costs?

    Sep 1, 2014, 00:00
  • Pharmaceutical Portfolio Management- Global Disease Burden and Corporate Performance Metrics

    Sep 1, 2014, 00:00
  • Validation of the IMS CORE Diabetes Model

    Sep 1, 2014, 00:00
  • Editorial Board

    Sep 1, 2014, 00:00
  • Response to Lai et al., “Development of a Symptom Index for Patients with Primary Brain Tumors”

    Sep 1, 2014, 00:00
  • Cancer Chemotherapy Treatment Patterns and Febrile Neutropenia in the US Veterans Health Administration

    Sep 1, 2014, 00:00
  • Dynamic Medication Adherence Modeling in Primary Prevention of Cardiovascular Disease- A Markov Microsimulation Methods Application

    Sep 1, 2014, 00:00
  • Table of Contents

    Jul 1, 2014, 00:00
  • NICE’s Selective Application of Differential Discounting- Ambiguous, Inconsistent, and Unjustified

    Jul 1, 2014, 00:00
  • Copyright/Subscription

    Jul 1, 2014, 00:00
  • A Framework to Evaluate the Cost-Effectiveness of the NADiA ProsVue Slope to Guide Adjuvant Radiotherapy among Men with High-Risk Characteristics Following Prostatectomy for Prostate Cancer

    Jul 1, 2014, 00:00
  • PRO Data Collection in Clinical Trials Using Mixed Modes- Report of the ISPOR PRO Mixed Modes Good Research Practices Task Force

    Jul 1, 2014, 00:00
  • Chinese Time Trade-Off Values for EQ-5D Health States

    Jul 1, 2014, 00:00
  • Comparison of Contemporaneous EQ-5D and SF-6D Responses Using Scoring Algorithms Derived from Similar Valuation Exercises

    Jul 1, 2014, 00:00
  • An Updated Method for Risk Adjustment in Outcomes Research

    Jul 1, 2014, 00:00
  • Time Is Money, But How Much? The Monetary Value of Response Time for Thai Ambulance Emergency Services

    Jul 1, 2014, 00:00
  • Cognitive Overload? An Exploration of the Potential Impact of Cognitive Functioning in Discrete Choice Experiments with Older People in Health Care

    Jul 1, 2014, 00:00
  • Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease- Cross-Model Comparison of Hypothetical Treatment Scenarios

    Jul 1, 2014, 00:00
  • Two Approaches to Incorporate Clinical Data Uncertainty into Multiple Criteria Decision Analysis for Benefit-Risk Assessment of Medicinal Products

    Jul 1, 2014, 00:00
  • Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments—A Collaboration between the European Medicines Agency and the European network for Health Technology Assessment

    Jul 1, 2014, 00:00
  • Review of the Task Force Report on PRO Data Collection in Clinical Trials Using Mixed Modes

    Jul 1, 2014, 00:00
  • Should I Stay or Should I Go Home? A Latent Class Analysis of a Discrete Choice Experiment on Hospital-At-Home

    Jul 1, 2014, 00:00
  • Treating to Target with Etanercept in Rheumatoid Arthritis- Cost-Effectiveness of Dose Reductions When Remission Is Achieved

    Jul 1, 2014, 00:00
  • A Comparison of National Guidelines for Network Meta-Analysis

    Jul 1, 2014, 00:00
  • The Effects of Total Knee Arthroplasty on Physical Functioning and Health among the Under Age 65 Population

    Jul 1, 2014, 00:00
  • An Economic Evaluation of Salt Reduction Policies to Reduce Coronary Heart Disease in England- A Policy Modeling Study

    Jul 1, 2014, 00:00
  • A Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension versus Standard Pump Therapy for Hypoglycemic Unaware Patients with Type 1 Diabetes

    Jul 1, 2014, 00:00
  • Editorial Board

    Jul 1, 2014, 00:00
  • The Role of Economic Evaluation in Meeting IOM’s Recommendations on Delivering High-Quality Cancer Care

    Jul 1, 2014, 00:00
  • Physician Social Networks and Variation in Rates of Complications After Radical Prostatectomy

    Jul 1, 2014, 00:00
  • The Effect of Presenting Information about Invasive Follow-Up Testing on Individuals’ Noninvasive Colorectal Cancer Screening Participation Decision- Results from a Discrete Choice Experiment

    Jul 1, 2014, 00:00
  • Instructions for Authors

    Jul 1, 2014, 00:00
  • In the paper “A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making- An ISPOR-AMCP-NPC Good Practice Task Force Report” published in Value in Health, Volume 17 (March/April 20 ...

    Jun 1, 2014, 00:00
  • A Review of FDA Warning Letters and Notices of Violation Issued for Patient-Reported Outcomes Promotional Claims between 2006 and 2012

    Jun 1, 2014, 00:00
  • Review of Utility Values for Economic Modeling in Type 2 Diabetes

    Jun 1, 2014, 00:00
  • Patient-Centeredness in the Design of Clinical Trials

    Jun 1, 2014, 00:00
  • Cost-Effectiveness of a Computerized Provider Order Entry System in Improving Medication Safety Ambulatory Care

    Jun 1, 2014, 00:00
  • Multicriteria Decision Analysis in the Reimbursement of New Medical Technologies- Real-World Experiences from Hungary

    Jun 1, 2014, 00:00
  • Is the UK NICE “Reference Case” Influencing the Practice of Pediatric Quality-Adjusted Life-Year Measurement within Economic Evaluations?

    Jun 1, 2014, 00:00
  • Instructions for Authors

    Jun 1, 2014, 00:00
  • Searching for Indirect Evidence and Extending the Network of Studies for Network Meta-Analysis- Case Study in Venous Thromboembolic Events Prevention Following Elective Total Knee Replacement Surgery

    Jun 1, 2014, 00:00
  • Estimation of Potential Gain in Quality of Life from Early Detection of Cervical Cancer

    Jun 1, 2014, 00:00
  • Long-Term Air Humidification Therapy Is Cost-Effective for Patients with Moderate or Severe Chronic Obstructive Pulmonary Disease or Bronchiectasis

    Jun 1, 2014, 00:00
  • Bazedoxifene versus Oral Bisphosphonates for the Prevention of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis at Higher Risk of Fracture- A Network Meta-Analysis

    Jun 1, 2014, 00:00
  • Discrete Choice Experiment to Estimate Breast Cancer Patients’ Preferences and Willingness to Pay for Prophylactic Granulocyte Colony-Stimulating Factors

    Jun 1, 2014, 00:00
  • A Retrospective, Observational Study of Patient Outcomes for Critically Ill Patients Receiving Parenteral Nutrition

    Jun 1, 2014, 00:00
  • Sharing Risk between Payer and Provider by Leasing Health Technologies- An Affordable and Effective Reimbursement Strategy for Innovative Technologies?

    Jun 1, 2014, 00:00
  • A Study of the Relationship between Health and Subjective Well-Being in Parkinson’s Disease Patients

    Jun 1, 2014, 00:00
  • Comparative Cost Analysis of Clinical Reminder for HIV Testing at the Veterans Affairs Healthcare System

    Jun 1, 2014, 00:00
  • A Comparison of Hong Kong and United Kingdom SF-6D Health States Valuations Using a Nonparametric Bayesian Method

    Jun 1, 2014, 00:00
  • Modeling a Preference-Based Index for Two Condition-Specific Measures (Asthma and Overactive Bladder) Using a Nonparametric Bayesian Method

    Jun 1, 2014, 00:00
  • Copyright/Subscription

    Jun 1, 2014, 00:00
  • Cost-Effectiveness of Second-Generation Antipsychotics for the Treatment of Schizophrenia

    Jun 1, 2014, 00:00
  • Development of a Scale to Assess Performance Following Primary Total Knee Arthroplasty

    Jun 1, 2014, 00:00
  • Patient Preferences for Treatment of Low Back Pain—A Discrete Choice Experiment

    Jun 1, 2014, 00:00
  • Editorial Board

    Jun 1, 2014, 00:00
  • Construct Validity of the Swedish Version of the Revised Piper Fatigue Scale in an Oncology Sample—A Rasch Analysis

    Jun 1, 2014, 00:00
  • Table of Contents

    Jun 1, 2014, 00:00
  • A Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol

    Jun 1, 2014, 00:00
  • The Impact of Differences between Patient and General Population EQ-5D-3L Values on the Mean Tariff Scores of Different Patient Groups

    Jun 1, 2014, 00:00
  • Questioning Patient Subgroups for Benefit Assessment- Challenging the German Gemeinsamer Bundesausschuss Approach

    Jun 1, 2014, 00:00
  • Medical Device Reimbursement Coverage and Pricing Rules in Korea- Current Practice and Issues with Access to Innovation

    Jun 1, 2014, 00:00
  • what happens when personalized medicine guidelines don’t agree? A systematic review of clinical guidelines for thiopurine methyltransferase testing for dose selection of thiopurines

    May 1, 2014, 00:00
  • Estimating Long-Term Functional Impairments Of Rheumatoid Arthritis- Integration Of Nationwide Survival With Health Assessment From Clinical Cohort

    May 1, 2014, 00:00
  • A Randomized Clinical Study to Evaluate Effects of Eicosapentaenoic Acid Enriched Oral Nutritional Supplement Along with Radio-Chemotherapy in Patients with Colorectal Carcinoma- A Cost-Effectiveness Analysis

    May 1, 2014, 00:00
  • Health Care Utilization And Costs Among Privately Insured Children With Orofacial Clefts

    May 1, 2014, 00:00
  • Opportunities For The Future Of United States Medical Device Surveillan An Analysis Of The Joint Replacement Registry (Jrr) Landscape In The United States

    May 1, 2014, 00:00
  • Validation Of The United States Huntington’s Disease Quality Of Life Battery For Carers

    May 1, 2014, 00:00
  • Dealing with competing risks in diabetes mellitus- Comparison of results using a markov versus a Micro-Markov simulation model

    May 1, 2014, 00:00
  • Value Of A Zero-Copay Drug Program- Implication For Employee Wellness Programs

    May 1, 2014, 00:00
  • Prevalence Of Prescription Medication Use Not Captured By Prescription Claims Databases

    May 1, 2014, 00:00
  • Length Of Stay And Mortality In Hyperphosphatemia Patients Administered Phosphate Binders Compared With Matched Controls

    May 1, 2014, 00:00
  • Shortages Of Drugs With Approved Orphan Indications In The United States

    May 1, 2014, 00:00
  • Survival crossover adjustment and cost effectiveness analysis- An empirical and methodological review with application

    May 1, 2014, 00:00
  • The Use Of Pillbox And Time In Therapeutic Range Among New Users Of Warfarin- A Propective Cohort Study

    May 1, 2014, 00:00
  • Eq-5d- Which Dimension Matters Most Among Diabetes Patients

    May 1, 2014, 00:00
  • Economic Evaluation- A Challenge In Incorporating New Health Technologies To The Brazilian Public Health System (SUS)

    May 1, 2014, 00:00
  • Blood Pressure Testing At Community Pharmacies Promote Better Hypertension Management

    May 1, 2014, 00:00
  • Utilizing Nordic Registries To Support Health Economics Research In Rheumatic Diseases

    May 1, 2014, 00:00
  • Incidence of antipsychotic polypharmacy in the texas medicaid population

    May 1, 2014, 00:00
  • The Association Between Continuity Of Care And Potentially Inappropriate Concomitant Medication In Continuous Non-Steroidal Anti-Inflammatory Drug Users

    May 1, 2014, 00:00
  • Evaluation Of Association Between Diabetes Related Quality Measure Achievement And Diabetes Complications In A Medicare Advantage Population

    May 1, 2014, 00:00
  • The Impact Of Medical Device Use On Hospital Costs

    May 1, 2014, 00:00
  • Change in employment and work performance among caregivers

    May 1, 2014, 00:00
  • An Outcomes Model for High-Risk Non-Muscle-Invasive Bladder Cancer Treatment Options

    May 1, 2014, 00:00
  • Framingham risk score estimates higher CVD risk than UKPDS risk engine in newly diagnosed type 2 diabetes mellitus patients in North India

    May 1, 2014, 00:00
  • Progress In Personalized Medicine Is Slower Than Some Had Expected, Partly Because Of The Science And Partly Because Of Insufficient Economic Incentives, Particularly For Investing In Molecular Diagnostics (MDX)

    May 1, 2014, 00:00
  • Health Related Quality of Life in Patients with Metastatic, Relapsed, or Inoperable Squamous Cell Carcinoma of the Head and Neck in India

    May 1, 2014, 00:00
  • Identifying Trends And Impacts Of The Fda Guidance For Industry On Patient-Reported Outcomes (Pros) On Approved Product Labels, 2006–2013

    May 1, 2014, 00:00
  • Estimation Of Change In Prescription Drug Expenditures On The Reference Pricing System In South Korea

    May 1, 2014, 00:00
  • A Retrospective, Cross Sectional Study On The Real-World Values Of Cardiovascular Risk Factors Using A Health Care Database In Japan

    May 1, 2014, 00:00
  • Risk on using logistic regression to illustrate exposure-response relationship of infectious disease

    May 1, 2014, 00:00
  • Effectiveness Of Patient Care Planning Discussions In Improving Patient-Centred Outcomes For End-Of-Life Care- An Evidence-Based Analysis

    May 1, 2014, 00:00
  • A Mixed Treatment Comparison (Mtc) To Compare The Efficacy Of Botulinum Toxin Type A Treatments For Cervical Dystonia

    May 1, 2014, 00:00
  • Adherence barriers to ace-is and arbs among non-adherent hypertensive patients with diabetes enrolled in a medicare advantage plan

    May 1, 2014, 00:00
  • Portrayal Of Stereotypes In Direct To Consumer Advertising Of Anti-Psychotics And Statins

    May 1, 2014, 00:00
  • Cost-Utility Analysis Of Very Low-Protein Diet, Low-Protein Diet And Full-Protein Diet In Ckd Patients In China

    May 1, 2014, 00:00
  • Health Care Cost and Utilization Among Patients Treated with Stivarga

    May 1, 2014, 00:00
  • Long-Acting Muscarinic Antagonists (Lama) In Chronic Obstructive Pulmonary Disease (Copd)- A Rare Events Meta Analysis Of Clinically Relevant Adverse Events

    May 1, 2014, 00:00
  • Social network analysis of prescription patterns

    May 1, 2014, 00:00
  • Validation of the telephone-administered of the age and stage questionnaire and the revised-prescreening denver questionnaire- Results from the otis antidepressants in pregnancy study

    May 1, 2014, 00:00
  • Cost Consequence Analysis Of Apixaban Versus Warfarin In Patients With Atrial Fibrillation In The Mexican Public Health Sector

    May 1, 2014, 00:00
  • Evidence Based Approach To Evaluate And Improve Access To Medicines In Emerging Markets

    May 1, 2014, 00:00
  • A Novel Colorectal Cancer Model with Sessile Serrated Adenoma Pathway to Evaluate the Cost-Effectiveness of Various Screening Strategies

    May 1, 2014, 00:00
  • Treatment Of Neuropathic Pain With The Capsaicin 8% Patch Qutenzatm- Evaluation Of Time To Retreatment, Patch Usage And Pain Alleviation

    May 1, 2014, 00:00
  • Utilization, Costs And Reimbursement Of Inpatient Treatment Of Acute Bacterial Skin And Skin Structure Infections Among The Medicare Fee-For-Service Population

    May 1, 2014, 00:00
  • Association Between Cardiovascular Drugs and Colon Cancer

    May 1, 2014, 00:00
  • Safety Of Azithromycin Therapy In Patients With High Cardiovascular Risk- A Meta-Analysis Of Randomized Controlled Trials

    May 1, 2014, 00:00
  • Predicting heart failure recurrence after aortic valve replacement using a competing-risks model

    May 1, 2014, 00:00
  • Real-World Utilization Of Certolizumab Pegol (Czp) For The Treatment Of Rheumatoid Arthritis (Ra) In The United Kingdom

    May 1, 2014, 00:00
  • Improved bootstrap point and confidence interval estimation of the incremental cost-effectiveness ratio (ICER)

    May 1, 2014, 00:00
  • The Epidemiology Of Gaucher DiseaseA Comprehensive Review Of The Literature

    May 1, 2014, 00:00
  • Knowledge, Attitudes And Practice Pertaining To Depression Among General Practitioners In An Indian City

    May 1, 2014, 00:00
  • Increased In Acute Health Care Use Among People Living With Human Immunodeficiency Virus (Hiv) And Co-Morbid Depression In Ontario- A Longitudinal Study

    May 1, 2014, 00:00
  • Risk heterogeneity in clinical trials- An evaluation of 25 large clinical trials using individual patient data

    May 1, 2014, 00:00
  • Signs, Symptoms, And Existing Patient Reported Outcome (PRO) Measures In Community-Acquired Bacterial Pneumonia (CABP)- A Comprehensive Literature Review

    May 1, 2014, 00:00
  • Health Care Utilization Costs And Medication Use Patterns Of Tumor Necrosis Factor (Tnf) Inhibitors Among Texas Medicaid Patients Diagnosed With Rheumatoid Arthritis

    May 1, 2014, 00:00
  • Automatic development of clinical prediction models with genetic programming- A case study in cardiovascular disease

    May 1, 2014, 00:00
  • The Association of Chemotherapy Versus Hormonal Therapy and Health Outcomes Among Patients with Hormone Receptor-Positive, Her2-Negative Metastatic Breast Cancer- Experience From the Patient Perspective

    May 1, 2014, 00:00
  • Mediation analysis of effect of lurasidone on patient functioning in bipolar depression- Direct effects and indirect effects mediated through improvement in depression symptoms

    May 1, 2014, 00:00
  • The Effect of Herd Immunity in Different Human Papillomavirus Vaccination Strategies- An Economic Evaluation of the Best II Study

    May 1, 2014, 00:00
  • Conceputalizing A Model To Assess The Impact Of International Reference Pricing Reforms

    May 1, 2014, 00:00
  • Delayed Treatment Modifications For Patients With Type 2 Diabetes Mellitus (T2dm) With Very Poor Glycemic Control

    May 1, 2014, 00:00
  • Comparison of the doubly robust estimation method to the propensity score method in a diabetes-related comparative health economics study

    May 1, 2014, 00:00
  • Cost-Effectiveness Of Endometrial Ablation With The Novasure® System Versus Other Global Ablation Modalities And Hysterectomy For Treatment Of Abnormal Uterine Bleeding (Aub)- United States Commercial And Medicaid Payer Perspectives

    May 1, 2014, 00:00
  • Identifying and characterizing trajectories of qol in persons with advanced cancer- Important contributors to decreasing QOL in people with cancer

    May 1, 2014, 00:00
  • Evaluation Analysis Comparing Tiotropium With Salmeterol Or Ipratropium In Chronic Obstructive Pulmonary Disease In Taiwan

    May 1, 2014, 00:00
  • Evaluating Costs and Utilization of Prostate Cancer Patients with Bone Metastases in the Outpatient Hospital Setting

    May 1, 2014, 00:00
  • Use Of Economic Evidence To Inform Drug Reimbursement Decision Making- The Case For Ontario

    May 1, 2014, 00:00
  • From private sites to big data without compromising privacy- A case of neuroimaging data classification

    May 1, 2014, 00:00
  • Validity and reliability of the medical outcomes study short-form health survey version 2 (SF-12v2) among adults with autism

    May 1, 2014, 00:00
  • Walking Speed Predicts Work Status Due To Health In Community Dwelling Women- The Osteoarthritis Initiative (Oai)

    May 1, 2014, 00:00
  • The Real Impact of Quality of Life (QOL) Endpoints on Market Access Decisions Across Markets – A Case Study Of Oncology Products

    May 1, 2014, 00:00
  • Cardiovascular Agents - Most Common Class Involved In Adverse Drug Reactions In Indian Elderly Inpatients

    May 1, 2014, 00:00
  • Identifying Recent Trends In Health Technology Assessments For Crohn’s Disease

    May 1, 2014, 00:00
  • Mammographic Density in Association with Smoking Status and Smoking Histories in a Sample of Postmenopausal Women- Results From a Cross-Sectional Study

    May 1, 2014, 00:00
  • Costs Of Pilot Programs In Chicago-Based Centers For Population Health And Health Disparities- A Case For Team-Care?

    May 1, 2014, 00:00
  • Cost Effectiveness Analysis Of Respiratory Syncytial Virus Infection Prophylaxis In Children With Congenital Heart Disease

    May 1, 2014, 00:00
  • National Patterns In Prescription Medication Treatment For Diabetes- 2002-2010

    May 1, 2014, 00:00
  • An open research exchange for online patient feedback in pro development

    May 1, 2014, 00:00
  • Cost-Effectiveness Analysis Of Tenofovir/Emtricitabine And Abacavir/Lamivudine In Combination With Efavirenz Or Atazanavir/Ritonavir For Treatment-Naive Adults With Hiv-1 Infection In The United Kingdom

    May 1, 2014, 00:00
  • Patient Reported Outcomes In End Stage Renal Disease (Esrd) AnemiaA Comprehensive Review

    May 1, 2014, 00:00
  • Factors Associated with Repeat Mammography Screening in The Medicaid Population

    May 1, 2014, 00:00
  • The Historical Evolution Of China’s Drug Regulatory System

    May 1, 2014, 00:00
  • Views of health care providers on medical errors in Karachi, Pakistan

    May 1, 2014, 00:00
  • Literature Review Of Economic Models For The Treatment Of Parkinson’s Disease

    May 1, 2014, 00:00
  • Cost-Utility Analysis Of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared To Thiazide Diuretic-Based Treatment In An Elderly Hypertensive Population Considering Major Comorbidities At The Community Level

    May 1, 2014, 00:00
  • Factors Related With Direct Costs Of Residential Mental Health Services In São Paulo City, Brazil- Does Resident Profile Affect Costs?

    May 1, 2014, 00:00
  • Association Between Antidepressants And C – Reactive Protein Among Adults With Inflammatory Conditions – A Population-Based Study

    May 1, 2014, 00:00
  • Impact On Health Status And Disease Specific Quality Of Life Of Tofacitinib In Patients With Inadequate Response To Non-Biological Disease-Modifying Antirheumatic Drugs (Dmard) Versus Anti-Tumor Necrosis Factor Drugs (Anti-Tnf) In Colombia

    May 1, 2014, 00:00
  • Triptan Use For Migraine Headache Among Adults With Cardiovascular Risk

    May 1, 2014, 00:00
  • Recent Trends In Costs, Length Of Stay, And Mortality Associated With Infant Pertussis Hospitalizations In The United States

    May 1, 2014, 00:00
  • Psa Monitoring and Results Among Men with Non-Metastatic Prostate Cancer

    May 1, 2014, 00:00
  • Autism Prevalence In Children Among The United States Medicaid Population

    May 1, 2014, 00:00
  • Meta-Analysis Of Il-2 Receptor Antagonist (Il-2 Ra) As Induction Therapy In Pediatric Renal Transplantation

    May 1, 2014, 00:00
  • The Rise Of Hospitalizations Due To Staphylococcus Aureus Skin And Soft Tissue Infections (Sstis) Among United States Children From 2001 To 2010

    May 1, 2014, 00:00
  • Public And Private Payer Perspectives On The Net Cost Of Implementation Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Compared With 7-Valent Pneumococcal Conjugate Vaccine (PCV7) To In The United States

    May 1, 2014, 00:00
  • Quantifying The Value Of Transitional Care Pharmacy Services

    May 1, 2014, 00:00
  • Efficacy, Safety and Cost-Effectiveness of Trastuzumab in Metastatic Gastric Cancer Treatment in China

    May 1, 2014, 00:00
  • Validation Of The Huntington Clinical Self-Reported Instrument (H-Csri) In United States

    May 1, 2014, 00:00
  • The Impact Of Oral Nutritional Supplementation In Medicare Patients With Copd

    May 1, 2014, 00:00
  • Natural History Of Metastatic Prostate Cancer In Clinical Practice

    May 1, 2014, 00:00
  • The Economic Burden On The Social Security System Pensions For Musculoskeletal Disorders In Italy

    May 1, 2014, 00:00
  • A Probabilistic Budget Impact Analysis Of Cystic Fibrosis Therapy On Health Plan Pharmacy Budgets

    May 1, 2014, 00:00
  • Cost-effectiveness of paliperidone palmitate versus olanzapine, quetiapine and ziprazidone for the treatment of patients with schizophrenia under the brazilian private health care system perspective

    May 1, 2014, 00:00
  • Military Veterans’ Perceptions Of Disagreement With Their Provider Regarding Their Medically Unexplained Symptoms Are Associated With Lower Satisfaction And Intentions To Adhere To Treatment And Poorer Health-Outcome Expectations

    May 1, 2014, 00:00
  • Treatment Persistence Comparison Between Nebulized Formulations Of Arformoterol And Formoterol In The Treatment Of Chronic Obstructive Pulmonary Disease

    May 1, 2014, 00:00
  • A Long War Begins- Biosimilars Versus Patented Biologics – A Retrospective Analysis Of The Eu-5 And Japanese Erythropoetins Markets

    May 1, 2014, 00:00
  • Economics Analysis Of Diagnostic Methods For Clostridium Difficile Infection

    May 1, 2014, 00:00
  • Persistence On Antiretroviral Therapy In Women Enrolled In The Wihs Cohort- 1998-2013

    May 1, 2014, 00:00
  • Estimating The Cost Of Treating Hypoglycemc Events In The Mexican Public Health Care System

    May 1, 2014, 00:00
  • Systematic Literature Review Of Compliance And Persistence Programs In Inflammation And Immunology

    May 1, 2014, 00:00
  • Orphan Drug Policies- Looking Backward, Thinking Forward

    May 1, 2014, 00:00
  • Identification Of Reasons For Non-Adherence And Elicitation Of Health-Related Quality Of Life Concepts Associated With Immunosuppressant Therapy In Kidney Transplant Recipients

    May 1, 2014, 00:00
  • The correspondence between patient-reported outcome (PRO) instruments and measures of disease activity in adult patients with mild-to-moderate ulcerative colitis (UC) receiving short-term daily treatment with mmx mesalamine

    May 1, 2014, 00:00
  • Perceived Benefits And Barriers Of Payer-Manufacturer Post-Marketing Outcomes Study Collaborations

    May 1, 2014, 00:00
  • Incremental Burden of Anastomotic Leaks in Colorectal Surgeries

    May 1, 2014, 00:00
  • Economic Evaluation Of A Comprehensive Care At Home Program In Patients Of The Mexican Institute Of Social Security With Multiple Sclerosis

    May 1, 2014, 00:00
  • Economic Impact Of Vaccination With 10-Valent Versus 13-Valent Pneumococcal Conjugated Vaccines In Colombia

    May 1, 2014, 00:00
  • Cost Of Intraveneous Patient-Controlled Analgesia (Iv Pca) Equipment And Opioid Medication For Orthopedic And Abdominal Surgeries In United States Hospitals

    May 1, 2014, 00:00
  • Health Care Resource Utilization And Costs In A Sample Of Real-World Patients With Severe Hypertriglyceridemia

    May 1, 2014, 00:00
  • Causal inferen Cognitive functioning and depressive symptoms by longitudinal marginal structure model

    May 1, 2014, 00:00
  • Simulation and Comparison of Progression-Free Survival (Pfs) Among Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Receiving Sequential Therapy

    May 1, 2014, 00:00
  • The Humanistic And Economic Burden Of Restless Legs Syndrome

    May 1, 2014, 00:00
  • Data quality with mixed-mode administration of the short form-36

    May 1, 2014, 00:00
  • Literature Review on Total Medical Costs and Cost Components of Oncology Care in the United States

    May 1, 2014, 00:00
  • Patient-Reported Outcome (Pro) Claims In Products Indicated For The Treatment Of Rare Diseases And Approved By The European Medicines Agency (Ema)

    May 1, 2014, 00:00
  • Pneumococcal Vaccine Targeting Strategy For The Older Adults- Customized Risk Profiling

    May 1, 2014, 00:00
  • Rituximab As First Choice For Patients With Refractory Rheumatoid Arthritis- A Systematic Review And Cost-Effectiveness Analysis

    May 1, 2014, 00:00
  • Simvastatin And Its Potential Drug Interactions- An Analysis Of Safety Signal Based On Fda Aers Database

    May 1, 2014, 00:00
  • Applicability of the new instrument for assessment of hypoglycemia symptoms in diabetes mellitus patients

    May 1, 2014, 00:00
  • Life years lost and lifetime health care expenditures associated with diabetes in the United States

    May 1, 2014, 00:00
  • «
  • 101
  • 102
  • 103 (current)
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • »